Search all trials

Find therapies in clinical trials near you – page 36

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Glioblastoma multiforme+1

Not recruiting

Registered drugNo placebo

Study on Early Temozolomide Treatment for Adults with Glioblastoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Temozolomide

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drug

Study of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not recruiting

Registered drug

Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Brentuximab Vedotin

Contact Research Centre

Leiomyosarcoma metastatic

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Filgrastim

Contact Research Centre

Kidney transplant rejection

Not recruiting

Registered drugNo placebo

Study on Tegoprubart for Preventing Kidney Transplant Rejection in Patients

Registered drugNo placebo

France

Participants:18–64 years
Substances:At-1501

Contact Research Centre

Plasma cell myeloma

Not recruiting

InvestigationalNo placebo

Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Find therapies in clinical trials near you – page 36

468 trials match your criteria

Breast cancer+1

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Glioblastoma multiforme+1

Study on Early Temozolomide Treatment for Adults with Glioblastoma

Plasma cell myeloma refractory

Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Atrial fibrillation+2

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Hepatocellular carcinoma

Study of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer

Non-small cell lung cancer

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Diffuse large B-cell lymphoma refractory

Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Leiomyosarcoma metastatic

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Kidney transplant rejection

Study on Tegoprubart for Preventing Kidney Transplant Rejection in Patients

Plasma cell myeloma

Study of Daratumumab Injection for Patients with High-Risk Smoldering Multiple Myeloma

Non-small cell lung cancer

Study of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Non-small cell lung cancer

Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.